NCT03033589View on ClinicalTrials.gov

Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

December 31, 2017

Conditions
Pain
Interventions
DRUG

Marcaine 0.25 % Injectable Solution

For the adductor canal block, 20 mL of 0.25% marcaine will be injected with the use of ultrasound guidance into the adductor canal by the attending anesthesiologist on the case in the pre-op holding area.

DRUG

Marcaine 0.25 % Injectable Solution

For the femoral nerve block, 30 mL of 0.25% marcaine will be injected with the use of ultrasound guidance around the femoral nerve sheath by the attending anesthesiologist on the case in the pre-op holding area.

Trial Locations (1)

48202

Henry Ford Health System - CFP 642, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT03033589 - Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength | Biotech Hunter | Biotech Hunter